Showing 1 - 1 results of 1 for search 'Makoto Ohmiya', query time: 0.02s Refine Results
  1. 1
    The KCNH3 inhibitor ASP2905 shows potential in the treatment of attention deficit/hyperactivity disorder.

    The KCNH3 inhibitor ASP2905 shows potential in the treatment of attention deficit/hyperactivity disorder. by Shinji Takahashi, Makoto Ohmiya, Sokichi Honda, Keni Ni

    Published 2018-01-01
    Get full text
    Article

Search Tools: